Global POC Cholesterol Testing Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global POC (Point-of-Care) Cholesterol Testing Market was valued at USD 1.8 billion in 2023 and is projected to reach USD 3.1 billion by 2031, growing at a CAGR of 6.9% during the forecast period of 2023–2031. This market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases, rising demand for portable diagnostic solutions, and a strong push toward decentralized healthcare. POC cholesterol testing offers the advantages of rapid diagnosis, real-time monitoring, and better accessibility in both clinical and home settings, which is crucial in managing hyperlipidemia and preventing heart-related complications.

Drivers

1. Rising Incidence of Cardiovascular Diseases:

The global burden of cardiovascular diseases continues to grow, leading to a higher demand for cholesterol monitoring solutions. POC devices enable early detection and routine monitoring, making them vital in disease prevention and health management.

2. Increasing Preference for Home Testing:

The convenience and time-saving benefits of at-home cholesterol testing have led to higher adoption among patients, especially the elderly and those with chronic conditions. This shift is further supported by the growing trend toward self-care and telemedicine.

3. Technological Advancements:

Innovations such as Bluetooth-enabled POC devices, smartphone integration, and multi-analyte testing platforms are significantly enhancing the user experience and diagnostic accuracy, driving further market expansion.

Restraints

1. Variability in Test Accuracy:

POC cholesterol testing devices may exhibit differences in accuracy compared to centralized laboratory testing, especially in less-regulated regions. This variability can impact clinical decision-making and limit adoption.

2. Regulatory Hurdles:

Stringent regulatory approvals for diagnostic devices can delay product launches and restrict market entry for newer players, particularly in regions with complex healthcare compliance frameworks.

Opportunity

1. Expansion in Emerging Markets:

Developing countries are witnessing a surge in chronic diseases alongside growing awareness of preventive healthcare. Governments and private health providers in regions like Asia-Pacific and Latin America are increasingly adopting POC technologies to bridge the diagnostic gap.

2. Integration with Digital Health Platforms:

The integration of POC devices with electronic health records (EHR) and telehealth solutions presents vast opportunities to streamline patient management and enhance remote monitoring capabilities.

Market by System Type Insights

Based on system type, Handheld POC Cholesterol Devices accounted for the largest market share in 2023. These devices are user-friendly, portable, and ideal for both home and clinic use. Their popularity is driven by the need for quick, reliable cholesterol readings without the need for specialized lab infrastructure.

The Benchtop Devices segment is also gaining traction in hospital and pharmacy settings, offering higher throughput for multiple patient screenings.

Market by End-use Insights

By end-use, the Hospitals & Clinics segment dominated the market in 2023 due to the high volume of patient traffic and the necessity for immediate diagnostic results in acute care settings.

The Homecare Settings segment is projected to witness the highest growth rate during the forecast period. The growing elderly population, coupled with the convenience of home monitoring and increasing availability of user-friendly devices, supports this trend.

Market by Regional Insights

Regionally, North America held the largest market share in 2023, fueled by the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of diagnostic innovations.

Asia-Pacific is expected to register the fastest growth during the forecast period. The region benefits from a large patient population, rising disposable incomes, and increasing awareness of chronic disease management.

Competitive Scenario

Key players operating in the Global POC Cholesterol Testing Market include:

Abbott Laboratories

F. Hoffmann-La Roche Ltd

Siemens Healthineers

PTS Diagnostics

Nova Biomedical

AccuTech

Quest Diagnostics

Alere Inc.

Randox Laboratories

EKF Diagnostics

These companies are focusing on innovations, product miniaturization, strategic partnerships, and global expansion. For instance:

In 2023, Abbott launched a new generation of connected cholesterol monitoring kits designed for seamless integration with mobile health apps.

In 2024, PTS Diagnostics collaborated with telemedicine platforms to offer cholesterol test kits bundled with virtual care services.

In 2025, Nova Biomedical introduced a multi-analyte POC device capable of testing lipid profile, glucose, and HbA1c on a single cartridge.

Scope of Work – Global POC Cholesterol Testing Market

Report Metric Details

Market Size (2023) USD 1.8 Billion

Projected Market Size (2031) USD 3.1 Billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Handheld Devices, Benchtop Devices), By End-use (Hospitals & Clinics, Homecare Settings, Diagnostic Centers)

Growth Drivers Rising cardiovascular cases, preference for home testing, rapid device innovation

Opportunities Expansion in emerging markets, digital integration of diagnostic tools

Key Market Developments

2023: Abbott launched Bluetooth-enabled cholesterol POC devices integrated with digital tracking for home users.

2024: Roche Diagnostics introduced cloud-based analytics support for real-time monitoring of cholesterol metrics.

2025: Siemens Healthineers acquired a diagnostics startup specializing in lipid profile miniaturization technologies.

FAQs

1) What is the current market size of the Global POC Cholesterol Testing Market?

The market was valued at USD 1.8 billion in 2023.

2) What is the major growth driver of the Global POC Cholesterol Testing Market?

The major growth driver is the increasing demand for rapid and accessible cholesterol monitoring due to the rising incidence of cardiovascular diseases.

3) Which is the largest region during the forecast period in the Global POC Cholesterol Testing Market?

North America is expected to maintain the largest market share during the forecast period.

4) Which segment accounted for the largest market share in the Global POC Cholesterol Testing Market?

The Handheld POC Cholesterol Devices segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global POC Cholesterol Testing Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, PTS Diagnostics, and Nova Biomedical.